🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

If you are attending #ECCO2025, don’t miss our Meet The Expert session where we will discuss the latest clinical data on treatment in #IBD. Find them at Celltrion booth (Hall 2.2)! 📌 Meet Prof. Stefan Schreiber and Dr. Julia Husman on Friday, 21 February, 15:10-15:40 CET 📌

BREAKING NEWS: We are thrilled to announce that the European Commission granted marketing authorization for our two #biosimilars in the European market. This announcement further expands Celltrion’s diverse biosimilar portfolio. We are committed to providing patient-centric care

Today, at #ECCO2025, we presented our latest data, which includes multiple post hoc analyses from the LIBERTY study. These insights underscore our commitment to improving patient outcomes through breakthrough #IBD research. View the press release here: bit.ly/3Qrhuov

We are excited to launch our first on-site congress activity of 2025 at this year’s ECCO! Come by Booth 15 at Hall 2.2b (Level 2) and discover our unwavering commitment to pursuing scientific solutions for patients with pressing unmet needs. 💡 #ECCO2025

BREAKING NEWS: We are delighted to announce that the European Commission has approved Celltrion’s treatment for #rheumatic diseases. This represents a significant advancement in our commitment to people living with autoimmune diseases in Europe. View press release here:

Today we announced our full year and Q4 2024 earnings release. Read full report at: bit.ly/4dBPTLc

As global citizens, we believe it is our responsibility to preserve the health and cleanliness of our planet. 🌍 At Celltrion, we are dedicated to environmental sustainability, and we continuously aim to minimizing our environmental impact and drive positive change for a better

#Biosimilars positively impact not only individual patient access to treatment but also the healthcare system as a whole. ​ Listen to our interview with Prof. João Manuel Braz Gonçalves, Full Professor in Faculty of Pharmacy at Universidade de Lisboa, in which he discusses the

At Celltrion, everything we do is driven by our strong sense of purpose. A purpose to help millions of patients have healthier lives. We also believe that the well-being of our employees and communities is just as important. From fostering an inclusive workplace, to ensuring

Hear from Prof. Giorgio Walter Canonica, Professor & Senior Consultant in Personalized Medicine Asthma & Allergy Clinic at Humanitas University & Research Hospital, as he shares his thoughts on the way to increase the adoption of #biosimilars in the field of respiratory and

Through strong leadership and smart decision-making, Celltrion is committed to exceeding boundaries and maintaining the highest standards for patients, stakeholders, and healthcare systems. Everyone at Celltrion approaches their work with ethics, transparency, and

Today we would like to spotlight Prof. Giorgio Walter Canonica and Prof. Alessandro Fiocchi, distinguished Italian allergists, and their discussion on the potential benefits of #biosimilars in improving patients access to treatment for allergic diseases. Tune in to find out more!

Welcome to the last edition of our #biosimilar video series. Wrapping up the discussion, Prof. João Manuel Braz Gonçalves, Full Professor in Faculty of Pharmacy at Universidade de Lisboa, shares his thoughts on the untapped opportunities in the biosimilars market that could

How can we make the future more #sustainable? From R&D to manufacturing and beyond, Celltrion is continuously striving to drive positive change for our planet. 🌍 This #EarthDay, discover how we're contributing to a healthier future through sustainable practices:

Allergic diseases affect people of all ages, genders, and ethnicities. This Global CRSwNP Awareness Day, Prof. Giorgio Walter Canonica from Humanitas University discusses the daily challenges faced by those with allergic asthma and #CRSwNP. Find more information on the Euforea

We're thrilled to welcome top gastroenterologists and rheumatologists from France to discuss the latest advancements in autoimmune disease treatments, biosimilars, and patient welfare! Kicking off our new video series, we have Prof. Anthony Buisson, gastroenterologist at

Severe #asthma can impact people both physically and psychologically. Hear from Prof. Jens Schreiber, MD, Head of Clinics for Pneumonology at University Hospital Magdeburg discussing the physical and psychological challenges that people living with severe asthma face.

Today we announced our Q1 2025 earnings release. Read full report at: bit.ly/4dBPTLc

Ahead of this year's #WorldIBDDay, we spotlight Prof. Mathurin Fumery, gastroenterologist at Amiens-Picardie University Hospital, who talks about the unmet needs of #IBD patients and how #biosimilars address these challenges. Tune in to find out more!